FBX-101

N/A

Report date: 2023/10/26 17:04:31

Base Information

Drug NameFBX-101
Drug Alias NameAAVrh.10-hGALCAAVrh.10-GALCFBX-101
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAVrh10 vector
Mechanisms of ActionGene transference
TargetsGalactocerebrosidase
Therapy Area/IndicationsLeukodystrophy, Globoid Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesForge Biologics
China Registration ClassN/A

Develop Information

Active CompaniesForge Biologics
Inactive CompaniesN/A
Active IndicationsLeukodystrophy, Globoid Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A